MECHANISM OF PROTECTIVE IMMUNITY INDUCED BY EBOLA VACCINES
MECHANISM OF PROTECTIVE IMMUNITY INDUCED BY EBOLA VACCINES
批准号:
8172781
负责人:
DAVID M ANDERSON
金额:
$15.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-05-01 至 2011-04-30
关键词:
Antibody FormationCD8B1 geneComputer Retrieval of Information on Scientific Projects DatabaseEbola Hemorrhagic FeverEbola VaccinesFundingGoalsGrantImmunityInstitutionMacaca fascicularisMeasuresModelingResearchResearch PersonnelResourcesRoleSourceT cell responseT-LymphocyteUnited States National Institutes of HealthVaccinesViral Antibodies
中文摘要
这个子项目是许多研究子项目中利用
资源由NIH/NCRR资助的中心拨款提供。子项目和
调查员(PI)可能从NIH的另一个来源获得了主要资金,
并因此可以在其他清晰的条目中表示。列出的机构是
该中心不一定是调查人员的机构。
这项研究的目的是通过测量VSV-ZEBOVgp产生的抗病毒抗体和T细胞反应的贡献,来询问埃博拉出血热NHP模型中的免疫决定因素。这将通过揭示CD8 T细胞对该疫苗在食蟹猴中引发的抗体反应的作用来实现。
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
The goal of this study is to interrogate the determinants of immunity in the NHP model of Ebola hemorrhagic fever, by measuring the contribution of antiviral antibody and T cell responses conferred by VSV-ZEBOVgp. This will be accomplished by uncovering the role of CD8 T cell versus antibody response elicited by this vaccine in Cynomolgus monkeys.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Washington National Primate Research Center
-
批准号:10008105
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2019
-
负责人:DAVID M ANDERSON
-
依托单位:
29th Annual Symposium for Nonhuman Primate Models for AIDS
-
批准号:8196705
-
项目类别:
-
资助金额:$7.47万
-
财政年份:2011
-
负责人:DAVID M ANDERSON
-
依托单位:
COMPARISON OF VACCINE REGIMENS: HIV-SIV RECOMBINANTS WITH PROTEIN BOOSTING
-
批准号:8357622
-
项目类别:
-
资助金额:$37.79万
-
财政年份:2011
-
负责人:DAVID M ANDERSON
-
依托单位:
SVEU HOLDING
-
批准号:8357621
-
项目类别:
-
资助金额:$49.29万
-
财政年份:2011
-
负责人:DAVID M ANDERSON
-
依托单位:
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES
-
批准号:8357593
-
项目类别:
-
资助金额:$37.79万
-
财政年份:2011
-
负责人:DAVID M ANDERSON
-
依托单位:
MECHANISM OF PROTECTIVE IMMUNITY INDUCED BY EBOLA VACCINES
-
批准号:8357611
-
项目类别:
-
资助金额:$15.66万
-
财政年份:2011
-
负责人:DAVID M ANDERSON
-
依托单位:
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY
-
批准号:8356908
-
项目类别:
-
资助金额:$184.47万
-
财政年份:2011
-
负责人:DAVID M ANDERSON
-
依托单位:
POST-EXPOSURE MONITORING OF LENTIVIRUS-INFECTED MACAQUES
-
批准号:8357594
-
项目类别:
-
资助金额:$37.79万
-
财政年份:2011
-
负责人:DAVID M ANDERSON
-
依托单位:
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES
-
批准号:8172752
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2010
-
负责人:DAVID M ANDERSON
-
依托单位:
POST-EXPOSURE MONITORING OF LENTIVIRUS-INFECTED MACAQUES
-
批准号:8172754
-
项目类别:
-
资助金额:$46.53万
-
财政年份:2010
-
负责人:DAVID M ANDERSON
-
依托单位:
WANPRC MACACA NEMESTRINA SPF BREEDING COLONY
-
批准号:8173573
-
项目类别:
-
资助金额:$180.47万
-
财政年份:2010
-
负责人:DAVID M ANDERSON
-
依托单位:
EFFICACY OF AN SIV VACCINE PREPARED WITH DIFFERENT ADJUVANTS
-
批准号:7958835
-
项目类别:
-
资助金额:$49.71万
-
财政年份:2009
-
负责人:DAVID M ANDERSON
-
依托单位:
SVEU HOLDING
-
批准号:7958828
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2009
-
负责人:DAVID M ANDERSON
-
依托单位:
POST-EXPOSURE MONITORING OF LENTIVIRUS-INFECTED MACAQUES
-
批准号:7958860
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2009
-
负责人:DAVID M ANDERSON
-
依托单位:
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES
-
批准号:7958856
-
项目类别:
-
资助金额:$33.14万
-
财政年份:2009
-
负责人:DAVID M ANDERSON
-
依托单位:
IN VIVO EVALUATION OF PRIMATE LENTIVIRUSES
-
批准号:7716386
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2008
-
负责人:DAVID M ANDERSON
-
依托单位:
SVEU HOLDING
-
批准号:7716346
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2008
-
负责人:DAVID M ANDERSON
-
依托单位:
LONG-TERM SURVIVORS OF SIV/HIV INFECTION
-
批准号:7716352
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2008
-
负责人:DAVID M ANDERSON
-
依托单位:
EFFICACY OF AN SIV VACCINE PREPARED WITH DIFFERENT ADJUVANTS
-
批准号:7716354
-
项目类别:
-
资助金额:$42.21万
-
财政年份:2008
-
负责人:DAVID M ANDERSON
-
依托单位:
RESEARCH SPECIMEN COLLECTION
-
批准号:7349318
-
项目类别:
-
资助金额:$29.38万
-
财政年份:2006
-
负责人:DAVID M ANDERSON
-
依托单位: